RT @profsmarshall: Up front & free to read in March's @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an u…
Cardiovascular outcome trials of glucose-lowering medications: an update https://t.co/lZN0M7njrx De un vistazo todos los estudios hasta la fecha. Falta el REWIND, pero están todos los demás.
RT @profsmarshall: Up front & free to read in March's @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an u…
RT @profsmarshall: Up front & free to read in March's @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an u…
RT @profsmarshall: Up front & free to read in March's @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an u…
Really good and comprehensive #CVOTs of glucose-lowering medications: an update | SpringerLink @ABCDiab @DiabetesUK @Mikevanderwatt https://t.co/Gz54Qxbimd
RT @profsmarshall: Up front & free to read in March's @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an u…
RT @profsmarshall: Up front & free to read in March's @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an u…
RT @profsmarshall: Up front & free to read in March's @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an u…
RT @profsmarshall: Up front & free to read in March's @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an u…
RT @profsmarshall: Up front & free to read in March's @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an u…
RT @profsmarshall: Up front & free to read in March's @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an u…
RT @profsmarshall: Up front & free to read in March's @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an u…
Up front & free to read in March's @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an update #CVOT #T2D https://t.co/I04jEkSn9j #editorspick
RT @ACinNYC2K19: CV benefits of GLP's, DPPiv's, SGLT-2's, etc. https://t.co/d8evHSfYnP #hearthealth #cardiology #endocrinology #diabetes #medicine #health
CV benefits of GLP's, DPPiv's, SGLT-2's, etc. https://t.co/wnONhagLZD #hearthealth #cardiology #endocrinology #diabetes #medicine #health
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl. Cardiovascular outcome trials of glucose-lowering medications: an update https://t.co…
RT @EstiUgarte: Cardiovascular outcome trials of glucose-lowering medications: an update | SpringerLink https://t.co/JmvdqeF17M
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl. Cardiovascular outcome trials of glucose-lowering medications: an update https://t.co…
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl. Cardiovascular outcome trials of glucose-lowering medications: an update https://t.co…
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl. Cardiovascular outcome trials of glucose-lowering medications: an update https://t.co…
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl. Cardiovascular outcome trials of glucose-lowering medications: an update https://t.co…
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl. Cardiovascular outcome trials of glucose-lowering medications: an update https://t.co…
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl. Cardiovascular outcome trials of glucose-lowering medications: an update https://t.co…
#OpenAccess in @DiabetologiaJnl. Cardiovascular outcome trials of glucose-lowering medications: an update https://t.co/QAYCyb9p62 https://t.co/08eOSg4rfS
RT @EstiUgarte: Cardiovascular outcome trials of glucose-lowering medications: an update | SpringerLink https://t.co/JmvdqeF17M
RT @IGOARANBAR: Esto no lo leeran los que miran la pela en lugar de ver a personas con #diabetESP 🤨🤨 https://t.co/LrCszzgo6R
Esto no lo leeran los que miran la pela en lugar de ver a personas con #diabetESP 🤨🤨
RT @EstiUgarte: Cardiovascular outcome trials of glucose-lowering medications: an update | SpringerLink https://t.co/JmvdqeF17M
Cardiovascular outcome trials of glucose-lowering medications: an update | SpringerLink https://t.co/JmvdqeF17M
RT @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an update #CVOT #T2D 🔓https://t.co/S7g1XX2if8 #toptweet
RT @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an update #CVOT #T2D 🔓https://t.co/S7g1XX2if8 #toptweet
RT @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an update #CVOT #T2D 🔓https://t.co/S7g1XX2if8 #toptweet
RT @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an update #CVOT #T2D 🔓https://t.co/S7g1XX2if8 #toptweet
RT @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an update #CVOT #T2D 🔓https://t.co/S7g1XX2if8 #toptweet
RT @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an update #CVOT #T2D 🔓https://t.co/S7g1XX2if8 #toptweet
Cardiovascular outcome trials of glucose-lowering medications: an update | SpringerLink https://t.co/PdfadHwGnv
Cardiovascular outcome trials of glucose-lowering medications: an update #CVOT #T2D 🔓https://t.co/S7g1XX2if8 #toptweet
RT @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an update #CVOT #T2D 🔓https://t.co/S7g1XWKHnA
RT @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an update #CVOT #T2D 🔓https://t.co/S7g1XWKHnA
RT @kamleshkhunti: Nice update on Cardiovascular outcome trials of glucose-lowering medications https://t.co/VBbuaB4IU2 @ADA_DiabetesPro…
Nice update on Cardiovascular outcome trials of glucose-lowering medications https://t.co/VBbuaB4IU2 @ADA_DiabetesPro @DiabetesCanada @AmDiabetesAssn @diabetesdaily @DiabetesMine @ACCANews @VascProtection @TheBHF @worldheartfed @escardio @American_Hear
RT @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an update #CVOT #T2D 🔓https://t.co/S7g1XWKHnA
RT @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an update #CVOT #T2D 🔓https://t.co/S7g1XWKHnA
【雑記】Diabetologia誌に、血糖低下薬による2型DM例CVイベント抑制に関する最新レビュー。 https://t.co/ZJt1LyESSq
RT @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an update #CVOT #T2D 🔓https://t.co/S7g1XWKHnA
Good review Cardiovascular outcome trials of glucose-lowering medications: an update | SpringerLink https://t.co/zgQuL8SwxS
RT @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an update #CVOT #T2D 🔓https://t.co/S7g1XWKHnA
RT @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an update #CVOT #T2D 🔓https://t.co/S7g1XWKHnA
RT @DiabetologiaJnl: Cardiovascular outcome trials of glucose-lowering medications: an update #CVOT #T2D 🔓https://t.co/S7g1XWKHnA
Cardiovascular outcome trials of glucose-lowering medications: an update #CVOT #T2D 🔓https://t.co/S7g1XWKHnA
RT @drjamesboyle: #CVOTs in glucose lowering trials update free @DiabetologiaJnl: GLP-1RA should be offered to all people with #CVD & #T2D;…
RT @drjamesboyle: #CVOTs in glucose lowering trials update free @DiabetologiaJnl: GLP-1RA should be offered to all people with #CVD & #T2D;…
RT @drjamesboyle: #CVOTs in glucose lowering trials update free @DiabetologiaJnl: GLP-1RA should be offered to all people with #CVD & #T2D;…
RT @drjamesboyle: #CVOTs in glucose lowering trials update free @DiabetologiaJnl: GLP-1RA should be offered to all people with #CVD & #T2D;…
#CVOTs in glucose lowering trials update free @DiabetologiaJnl: GLP-1RA should be offered to all people with #CVD & #T2D; #SGLT2I should be prescribed for those at high risk of #heartfailure or with progressive decline in eGFR @johnrpetrie @UofGICAMS h
Cardiovascular outcome trials of glucose-lowering medications: an update | SpringerLink https://t.co/15PRzRCzog
Cardiovascular outcome trials of glucose-lowering medications: an update by Philip Home. https://t.co/Y0KbDIZ65S
RT @DanielJDrucker: Expert Perspective from Philip Home @DiabetesUK Cardiovascular outcome trials of glucose-lowering medications #T2D an…
RT @DanielJDrucker: Expert Perspective from Philip Home @DiabetesUK Cardiovascular outcome trials of glucose-lowering medications #T2D an…
RT @DanielJDrucker: Expert Perspective from Philip Home @DiabetesUK Cardiovascular outcome trials of glucose-lowering medications #T2D an…
RT @JamesJosephIgoe: Cardiovascular outcome trials of glucose-lowering medications: an update https://t.co/OdoJoXYxWH via @instapaper
RT @JamesJosephIgoe: Cardiovascular outcome trials of glucose-lowering medications: an update https://t.co/OdoJoXYxWH via @instapaper
RT @DanielJDrucker: Expert Perspective from Philip Home @DiabetesUK Cardiovascular outcome trials of glucose-lowering medications #T2D an…
RT @DanielJDrucker: Expert Perspective from Philip Home @DiabetesUK Cardiovascular outcome trials of glucose-lowering medications #T2D an…
RT @DanielJDrucker: Expert Perspective from Philip Home @DiabetesUK Cardiovascular outcome trials of glucose-lowering medications #T2D an…
Very useful - some good points in that last section...
RT @DanielJDrucker: Expert Perspective from Philip Home @DiabetesUK Cardiovascular outcome trials of glucose-lowering medications #T2D an…
Expert Perspective from Philip Home @DiabetesUK Cardiovascular outcome trials of glucose-lowering medications #T2D an update @DiabetologiaJnl https://t.co/KOU7BpYDUd
Cardiovascular outcome trials of glucose-lowering medications: an update https://t.co/OdoJoXYxWH via @instapaper